Fourth quarter revenue expected to be $15.9 million to $16.1 million, representing growth of 4% to 5%Full year revenue ...
Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...
ASCs remain one of the most efficient sites of care, but growth in 2026 is far from guaranteed. From reimbursement pressure ...
What Is Driving the New Fair Value Estimate for Sight Sciences? Sight Sciences now carries a fair value estimate of US$9.35 ...
The probe began after STAT and others reported on UnitedHealth's strategies to boost profits in Medicare Advantage.
IceCure Medical Ltd. ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback